Literature DB >> 27032493

Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran.

Mohammad Hadizadeh1, Seyed H Abedi1, Habib Malekpour1, Ebrahim Radinnia1, Sayena Jabbehdari1, Maryam Padashi1, Mohammad R Zali1, Amir H Mohammad Alizadeh2.   

Abstract

BACKGROUND AND STUDY AIMS: In Iran, the epidemiology of primary sclerosing cholangitis (PSC) and its association with inflammatory bowel disease (IBD) have not been studied thoroughly. This study investigates the epidemiology and prevalence of IBD among patients with PSC. PATIENTS AND METHODS: A retrospective study of 154 patients with PSC was conducted. The demographic and clinical data were collected, and the variables were analysed in the following two patient groups: patients with both PSC and IBD, and patients with PSC and without IBD.
RESULTS: A total of 154 patients with a mean age of 40.3years (range 20-81years) were included, of whom 57 (37%) were female and 97 (63%) male. Ninety-six patients (62.3%) were diagnosed with IBD, 92 (59.7%) with ulcerative colitis, and four (2.6%) with Crohn's disease. In this study, elevated alkaline phosphatase levels were found in 90.8% of patients. The intra-hepatic duct (IHD) and extrahepatic duct (EHD) were involved in 70.5% of patients, isolated intrahepatic bile duct in 24.4%, and isolated extrahepatic duct in 3.8%. Small-duct PSC (normal results of imaging and PSC proved by histology of liver biopsy) was observed only in 1.3% of patients.
CONCLUSION: PSC has become increasingly diagnosed in Iran. This is possibly because of better diagnostics and the increasing prevalence of IBD in this country. For diagnosing PSC and identifying the presence of IHD strictures, the results of both magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography (ERCP) showed good interobserver agreement, but the ERCP results could be used to evaluate the presence and severity of EHD strictures.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Crohn’s disease; Inflammatory bowel disease; Primary sclerosing cholangitis; Ulcerative colitis

Mesh:

Substances:

Year:  2016        PMID: 27032493     DOI: 10.1016/j.ajg.2015.09.004

Source DB:  PubMed          Journal:  Arab J Gastroenterol        ISSN: 1687-1979            Impact factor:   2.076


  7 in total

Review 1.  The evolution of natural history of primary sclerosing cholangitis.

Authors:  Will R Takakura; James H Tabibian; Christopher L Bowlus
Journal:  Curr Opin Gastroenterol       Date:  2017-03       Impact factor: 3.287

2.  Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.

Authors:  Nahla Azzam; Yazed AlRuthia; Othman Alharbi; Abdulrahman Aljebreen; Majid Almadi; Edward V Loftus
Journal:  Hepatol Int       Date:  2020-12-28       Impact factor: 6.047

Review 3.  To screen or not to screen? Celiac antibodies in liver diseases.

Authors:  Janaína Luz Narciso-Schiavon; Leonardo Lucca Schiavon
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

4.  Label-free and washing-free alkaline phosphatase assay using a personal glucose meter.

Authors:  Jun Ki Ahn; Hyo Yong Kim; Chang Yeol Lee; Ki Soo Park; Hyun Gyu Park
Journal:  J Biol Eng       Date:  2019-06-04       Impact factor: 4.355

5.  Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population.

Authors:  Mateus Jorge Nardelli; Paulo Lisboa Bittencourt; Guilherme Grossi Lopes Cançado; Luciana Costa Faria; Cristiane Alves Villela-Nogueira; Vivian Rotman; Eliabe Silva de Abreu; Fernanda Maria Farage Osório; Andreia Silva Evangelista; Liliana Sampaio Costa Mendes; Daniel Ferraz de Campos Mazo; Elodie Bonfim Hyppolito; Adrielly de Souza Martins; Liana Codes; Izabelle Venturini Signorelli; Geisa Perez Medina Gomide; Luciana Agoglia; Claudia Alexandra Pontes Ivantes; Valéria Ferreira de Almeida E Borges; Gabriela Perdomo Coral; Rosamar Eulira Fontes Rezende; Maria Lucia Gomes Ferraz; Debora Raquel Benedita Terrabuio; Eduardo Luiz Rachid Cançado; Claudia Alves Couto
Journal:  Can J Gastroenterol Hepatol       Date:  2021-11-10

6.  Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom.

Authors:  Huifang Liang; Sudhakar Manne; Jesse Shick; Trevor Lissoos; Paul Dolin
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

Review 7.  Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents.

Authors:  Sho Hasegawa; Masato Yoneda; Yusuke Kurita; Asako Nogami; Yasushi Honda; Kunihiro Hosono; Atsushi Nakajima
Journal:  Drugs       Date:  2021-06-17       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.